BioSmart Research

Early Stage

BioSmart Research: nutraceutical CBD isolates for professional distribution

Analytics

Raised to Date: Raised: $53,400

Aggregate Commitments $

Platform

Wefunder

Start Date

07/14/2021

Close Date

12/22/2021

Min. Goal

$50,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

Convertible Note

Funding Type

RegCF

Series

Pre-Seed

Valuation Cap

$20,000,000

Discount Rate

20%

Rolling Commitments $

Status
Funded
Reporting Date

12/31/2021

Days Remaining
Funded
% of Min. Goal

107%

% of Max. Goal

5%

Likelihood of Max
Funded
Avg. Daily Raise

$332

Momentum
Funded
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Yelm, Washington

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

High

Business Type

Growth

BioSmart Research, with a valuation cap of $20 million, is raising funds on Wefunder. The company is making over-the-counter CBD nutraceuticals for pain management, anxiety, skincare, and neurological disorders. BioSmart Research uses chromatography technologies to produce specific cannabinoid formulas to treat specific conditions. B Renee Searle founded BioSmart Research in March 2019. The current crowdfunding round has a minimum target of $50,000 and a maximum target of $1,070,000, and the funds will be used for marketing expenses, paying off an existing equipment note, opening a retail dispensary, and inventories. BioSmart Research sells through its own dispensaries, healthcare providers, pharmacies, and affiliates and has generated $1.7 million in lifetime sales.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$52,952

$1,873,578

COGS

$0

$1,497,859

Tax

$0

$0

 

 

Net Income

$-149,247

$74,730

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$49,777

$68,970

Accounts Receivable

$0

$0

Total Assets

$2,627,387

$2,472,260

Short-Term Debt

$113,067

$2,314

Long-Term Debt

$127,210

$112,577

Total Liabilities

$240,277

$114,891

Financials as of: 07/14/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
BioSmart Research on Wefunder 2021
$
Platform: Wefunder
Security Type: Convertible Note
Valuation: $20,000,000

Follow company

Follow BioSmart Research on Wefunder 2021